alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I

103D CONGRESS

1ST SESSION H. R. 2647

To amend title 38, United States Code, to provide that the effective date

of any changes in benefits under the Servicemen’s Group Life Insurance

program shall be based on the International Date Line.

IN THE HOUSE OF REPRESENTATIVES

JULY 15, 1993

Mr. KREIDLER introduced the following bill; which was referred to the

Committee on Veterans’ Affairs

A BILL

To amend title 38, United States Code, to provide that

the effective date of any changes in benefits under the

Servicemen’s Group Life Insurance program shall be

based on the International Date Line.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. EFFECTIVE DATE FOR CHANGES IN SERVICE4 MEN’S GROUP LIFE INSURANCE PROGRAM.

5 (a) USE OF INTERNATIONAL DATE LINE.—Section

6 1967 of title 38, United States Code, is amended by add7 ing at the end the following new subsection:
2

•HR 2647 IH

1 ‘‘(f) The effective date and time for any change in

2 benefits under the Servicemen’s Group Life Insurance

3 program shall be based on the International Date Line.’’.

4 (b) EFFECTIVE DATE.—The amendment made by

5 subsection (a) shall apply with respect to amendments to

6 chapter 19 of title 38, United States Code, that take effect

7 after November 29, 1992.

Æ
State $4.00 $4.50 $5.00 $5.50 $6.00 $6.50 $7.00 $7.50 $8.00 Total

Alabama 3 1 1 27 32

Alaska 1 1

Arizona 54 8 62

Arkansas 1 1 42 44

California 387 4 1 491 883

Colorado 37 2 1 44 84

Connecticut 6 77 83

Delaware 19 19

Florida 14 1 35 50

Georgia 10 1 114 125

Hawaii

Idaho 80 1 201 282

Illinois 12 4 1 2 2 1 2 481 505

Indiana 29 2 2 2 310 345

Iowa 44 1 1 843 889

Kansas 31 5 1 2 2 1 1 153 196

Kentucky 7 290 297

Louisiana 89 89

Maine 8 192 200

Maryland 2 2 199 203

Massachusetts 2 1 105 108

Michigan 42 2 1 3 920 968

Minnesota 87 13 2 2 3 3 6 2,291 2,407

Mississippi 2 1 56 59

Missouri 15 1 4 1 1 454 476

Montana 7 2 1 49 59

Nebraska 15 1 125 141

Nevada 8 8 16

New Hampshire 2 1 75 78

New Jersey 39 39

New Mexico 116 1 3 120

New York 37 1 1 2,329 2,368

North Carolina 11 141 152

North Dakota 4 2 1 58 65

Ohio 31 4 7 910 952

Oklahoma 12 5 102 119

Oregon 19 139 158

Pennsylvania 23 9 2 1 2 2,028 2,065

Puerto Rico 1 230 231

Rhode Island 6 6

South Carolina 44 44

South Dakota 29 1 3 1 2 140 176

Tennessee 4 1 202 207

Texas 127 2 1 1 198 329

Utah 9 1 140 150

Vermont 5 3 1 584 593

Virginia 6 1 1 316 324

Washington 49 1 1 228 279

West Virginia 49 49

Wisconsin 219 2 23 2 1 10 5,675 5,932

Wyoming 1 5 6

Total 1,608 3 96 7 10 18 16 43 21,264 23,065

Table 2: Count of Dairy Operations by Coverage Level for 2018 Margin Protection Program (MPP)

January 12, 2023

Prepared by USDA/Farm Service Agency
<PAGE>

                                                                    EXHIBIT 23.1



                 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS


Board of Directors
Renaissance Golf Products, Inc.

We hereby consent to the incorporation by reference in the Registration
Statements on Forms S-8 (33-92586, 333-46047, 333-58791 and 333-67119) of our
report dated February 20, 1998, appearing in the Annual Report on Form 10-KSB of
Renaissance Golf Products, Inc. for the year ended December 31, 1998.




                                             /s/ Corbin & Wertz
                                             CORBIN & WERTZ


Irvine, California
April 14, 1999
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2461 Received in Senate (RDS)]

103d CONGRESS
  2d Session
                                H. R. 2461

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

            October 7 (legislative day, September 12), 1994

                                Received

_______________________________________________________________________

                                 AN ACT

 
 To amend the Federal Property and Administrative Services Act of 1949 
 to authorize the transfer to States of surplus personal property for 
donation to nonprofit providers of necessaries to impoverished families 
                            and individuals.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TRANSFER OF SURPLUS PERSONAL PROPERTY FOR DONATION TO 
              PROVIDERS OF NECESSARIES TO IMPOVERISHED FAMILIES AND 
              INDIVIDUALS.

    Section 203(j)(3)(B) of the Federal Property and Administrative 
Services Act of 1949 (40 U.S.C. 484(j)(3)(B)) is amended by inserting 
after ``homeless individuals'' the following: ``, providers of 
assistance to families or individuals whose annual incomes are below 
the poverty line (as that term is defined in section 673 of the 
Community Services Block Grant Act),''.

            Passed the House of Representatives September 27, 1994.

            Attest:

                                           DONNALD K. ANDERSON,

                                                                 Clerk.

                      By Dallas L. Dendy, Jr.,

                                                Assistant to the Clerk.
```
**Exhibit 23.1****CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**We consent to the incorporation by reference in Registration Statement Nos. 33-72086, 33-86040,333-05643, 333-56215, 333-42708, 333-101037, 333-107317, and 333-119262 on Forms S-8 of our reportdated April 10, 2007 (which report expresses an unqualified opinion and includes an explanatoryparagraph relating to the adoption of Statement of Financial Accounting Standards (“SFAS”) No.123(R), *Share-Based Payment*and SFAS No. 158, *Employers’ Accounting for Defined Benefit Pension andOther Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106, and 132(R)*), relatingto the financial statements of The Talbots, Inc. and subsidiaries and our report dated April 10,2007 relating to management’s report on the effectiveness of internal control over financialreporting, appearing in this Annual Report on Form 10-K of The Talbots, Inc. for the year endedFebruary 3, 2007./s/ Deloitte & Touche LLPBoston, Massachusetts
[Federal Register Volume 66, Number 37 (Friday, February 23, 2001)]
[Notices]
[Page 11300]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-4453]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel. ZHL1 CSR-J M2 R Sibling Donor Cord Blood 
Banking And Transplantation Applications.
    Date: March 13, 2001.
    Time: 3 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 6701 Rockledge Dr. II, NIH, Bethesda, MD 20892, 
(Telephone Conference Call).
    Contact Person: Robert B Moore, PhD, Scientific Review 
Administrator, Review Branch, Room 7192, Division of Extramural 
Affairs, National Heart, Lung, and Blood Institute, National 
Institutes of Health, Bethesda, MD 20892, 301/435-3541.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: February 14, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-4453 Filed 2-22-01; 8:45 am]
BILLING CODE 4140-01-M
#### UNITED STATES of America, Plaintiff—Appellee, v. Vincent JENNELL, Jr., Defendant—Appellant.

No. 10-7366.

United States Court of Appeals, Fourth Circuit.

Submitted: Jan. 13, 2011.

Decided: Jan. 20, 2011.

*726Vincent Jennell, Jr., Appellant Pro Se. Donald Ray Wolthuis, Assistant United States Attorney, Roanoke, Virginia, for Appellee.

Before MOTZ, KING, and WYNN, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Vincent Jennell, Jr., appeals a district court order denying his motion for an evidentiary hearing and appointment of counsel. We have reviewed the record and the district court’s order and affirm for the reasons cited by the district court. *See United States v. Jennell,*No. 7:02-cr-00032-jct-3 (W.D.Va. Sept. 9, 2010). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         851,102
<INT-BEARING-DEPOSITS>                       4,781,687
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                  6,427,784
<INVESTMENTS-CARRYING>                       3,104,261
<INVESTMENTS-MARKET>                         3,138,248
<LOANS>                                     95,327,769
<ALLOWANCE>                                    325,367
<TOTAL-ASSETS>                             113,977,631
<DEPOSITS>                                  90,313,658
<SHORT-TERM>                                 8,000,000
<LIABILITIES-OTHER>                          1,057,888
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     5,225,975
<OTHER-SE>                                   9,380,110
<TOTAL-LIABILITIES-AND-EQUITY>             113,977,631
<INTEREST-LOAN>                              8,011,909
<INTEREST-INVEST>                              501,115
<INTEREST-OTHER>                               218,366
<INTEREST-TOTAL>                             8,731,390
<INTEREST-DEPOSIT>                           4,275,930
<INTEREST-EXPENSE>                           4,653,544
<INTEREST-INCOME-NET>                        4,077,846
<LOAN-LOSSES>                                   23,500
<SECURITIES-GAINS>                             (5,994)
<EXPENSE-OTHER>                              2,239,808
<INCOME-PRETAX>                              1,972,323
<INCOME-PRE-EXTRAORDINARY>                   1,972,323
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,972,323
<EPS-PRIMARY>                                     1.43
<EPS-DILUTED>                                     1.30
<YIELD-ACTUAL>                                    3.96
<LOANS-NON>                                    533,000
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                               301,867
<CHARGE-OFFS>                                        0
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                              325,367
<ALLOWANCE-DOMESTIC>                           325,367
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
Exhibit
32.2




Certification
pursuant to Section 906 of Sarbanes-Oxley Act of 2002





I,
Gregory Krzemien, the Principal Financial Officer of Mace Security
International, Inc., hereby certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that the Form 10-K of Mace Security International,
Inc. for the year ended December 31, 2008 (the “December 31, 2008 Form 10-K”),
which this certification accompanies, fully complies with requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m (a)
or 78o(d)) and information contained in the December 31, 2008 Form 10-K fairly
presents, in all material respects, the financial condition and results of
operations of Mace Security International, Inc.




Dated:
March 25, 2009





/s/Gregory M. KrzemienGregory
      M. KrzemienPrincipal
      Financial Officer and Treasurer
<TABLE> <S> <C>


<ARTICLE>                     9
<LEGEND>
      The schedule contains summary financial information extracted from Form
10-KSB for the fiscal year ended June 30, 1999 and is qualified in its entirety
by reference to such financial statements.
</LEGEND>
<MULTIPLIER>                               1000

<S>                                  <C>
<PERIOD-TYPE>                            12-MOS
<FISCAL-YEAR-END>                   JUN-30-1999
<PERIOD-END>                        JUN-30-1999
<CASH>                                    8,481
<INT-BEARING-DEPOSITS>                      884
<FED-FUNDS-SOLD>                              0
<TRADING-ASSETS>                              0
<INVESTMENTS-HELD-FOR-SALE>               1,944
<INVESTMENTS-CARRYING>                        0
<INVESTMENTS-MARKET>                          0
<LOANS>                                  72,573
<ALLOWANCE>                                 242
<TOTAL-ASSETS>                           90,824
<DEPOSITS>                               54,713
<SHORT-TERM>                                 93
<LIABILITIES-OTHER>                       1,110
<LONG-TERM>                              18,784
<PREFERRED-MANDATORY>                         0
<PREFERRED>                                   0
<COMMON>                                      9
<OTHER-SE>                               16,114
<TOTAL-LIABILITIES-AND-EQUITY>           90,824
<INTEREST-LOAN>                           5,951
<INTEREST-INVEST>                           745
<INTEREST-OTHER>                              0
<INTEREST-TOTAL>                          6,696
<INTEREST-DEPOSIT>                        2,888
<INTEREST-EXPENSE>                        1,112
<INTEREST-INCOME-NET>                     2,696
<LOAN-LOSSES>                                36
<SECURITIES-GAINS>                            0
<EXPENSE-OTHER>                           1,926
<INCOME-PRETAX>                           1,507
<INCOME-PRE-EXTRAORDINARY>                1,507
<EXTRAORDINARY>                               0
<CHANGES>                                     0
<NET-INCOME>                              1,018
<EPS-BASIC>                              0.68
<EPS-DILUTED>                              0.67
<YIELD-ACTUAL>                             7.95
<LOANS-NON>                                   0
<LOANS-PAST>                                878
<LOANS-TROUBLED>                              0
<LOANS-PROBLEM>                               0
<ALLOWANCE-OPEN>                            206
<CHARGE-OFFS>                                 0
<RECOVERIES>                                  0
<ALLOWANCE-CLOSE>                           242
<ALLOWANCE-DOMESTIC>                        242
<ALLOWANCE-FOREIGN>                           0
<ALLOWANCE-UNALLOCATED>                     242



</TABLE>
I

103D CONGRESS

1ST SESSION H. R. 2694

To amend the Federal Food, Drug, and Cosmetic Act and the Public Health

Service Act to require special testing for drugs and biological products

used by women.

IN THE HOUSE OF REPRESENTATIVES

JULY 21, 1993

Mrs. SCHROEDER (for herself and Ms. SNOWE) introduced the following bill;

which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act and

the Public Health Service Act to require special testing

for drugs and biological products used by women.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Pharmaceutical Inter5 actions Safety Act’’.

6 SEC. 2. CLINICAL INVESTIGATIONS.

7 Section 505(b) of the Federal Food, Drug, and Cos8 metic Act is amended by adding at the end the following:
2

•HR 2694 IH

1 ‘‘(4) Clinical investigations to be submitted as part

2 of an application in accordance with paragraph (1)(A)

3 shall include investigations of the possible interaction of

4 the drug with relevant female or male hormones or related

5 substances unless there is substantial evidence that there

6 are no significant interactions between the drug under in7 vestigation and such substances or the inclusion of such

8 investigations is otherwise inappropriate under guidelines

9 established by the Secretary by rule.’’.

10 SEC. 3. BIOLOGICAL PRODUCTS CLINICAL INVESTIGA11 TIONS.

12 Section 351(c) of the Public Health Service Act (42

13 U.S.C. 262(c)) is amended by adding at the end the fol14 lowing:

15 ‘‘(3) Clinical investigations submitted as part of an

16 application for a biological product in accordance with

17 paragraph (1) shall include investigations of the possible

18 interaction of the biological product with relevant female

19 or male hormones or related substances unless there is

20 substantial evidence that there are no significant inter21 actions between the biological product under investigation

22 and such substances or the inclusion of such investigations

23 is otherwise inappropriate under guidelines established by

24 the Secretary by rule.’’.

Æ
CASE ANNOUNCEMENTS

*April 19, 2010*

[Cite as *0411912010 Case Announcements,*2010-Ohio-1709.]

MOTION AND PROCEDURAL RULINGS

2010-0129.

#### Am. Internatl. Recovery v. Allstate Ins. Co.

Portage App. No. 2009-P-0008, 2009-Ohio-6508. This cause is pending before the court as a discretionary appeal. On January 22, 2010, appellant filed a notice that a motion to certify a conflict was pending in the court of appeals and, pursuant to S.Ct.Prac.R. 4.4(A)(4), this court stayed consideration of the jurisdictional memoranda filed in this appeal. Whereas appellant has neither notified this court that the court of appeals determined that a conflict does not exist as provided by S.Ct.Prac.R. 4.4(B) nor filed a copy of the court of appeals’ order certifying the existence of a conflict as provided by S.Ct.Prae.R. 4.4(C),

It is ordered by the court, sua sponte, that appellant show cause within fourteen days of the date of this entry why this court should not proceed to consider the jurisdictional memoranda in this appeal pursuant to S.Ct.Prac.R. 3.6.

Pfeifer, Acting C.J.
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2505 Introduced in House (IH)]

103d CONGRESS
  1st Session
                                H. R. 2505

  To extend until January 1, 1998, the existing suspension of duty on 
       stuffed dolls, certain toy figures, and the skins thereof.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 23, 1993

 Mr. Machtley introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
  To extend until January 1, 1998, the existing suspension of duty on 
       stuffed dolls, certain toy figures, and the skins thereof.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. EXTENSION OF EXISTING SUSPENSION OF DUTY ON STUFFED DOLLS, 
              CERTAIN TOY FIGURES, AND THE SKINS THEREOF.

    Headings 9902.95.01, 9902.95.02, and 9902.95.04 of the Harmonized 
Tariff Schedule of the United States are each amended by striking ``12/
31/92'' and inserting ``12/31/97''.

SEC. 2. APPLICABILITY.

    (a) In General.--The amendments made by section 1 shall take effect 
on the 15th day after the date of the enactment of this Act.
    (b) Retroactive Provision.--Notwithstanding section 514 of the 
Tariff Act of 1930 or any other provision of law to the contrary, upon 
a request filed with the appropriate customs officer before the 180th 
day after the date of the enactment of this Act, any entry or 
withdrawal from warehouse for consumption of goods to which any 
amendment made by section 1 applies and that was made--
            (1) after December 31, 1992; and
            (2) before the 15th day after the date of the enactment of 
        this Act;
and with respect to which there would have been no duty or a lower duty 
if any amendment made by section 1 had applied to such entry or 
withdrawal, shall be liquidated or reliquidated as though such entry or 
withdrawal had occurred on such 15th day.

                                 <all>
```